Resumen
El 30 de enero de 2020, la Organización Mundial de la Salud (OMS) declaró el brote de COVID‑19 como emergencia epidemiológica. A nivel mundial han surgido diversos lineamientos para la seguridad de los pacientes que padecen enfermedad renal crónica (ERC) y el personal de salud que labora en centros de hemodiálisis. En México, la prevalencia de ERC es de 12.2% y 60 000 enfermos reciben alguna modalidad de terapia de reemplazo renal en el Instituto Mexicano del Seguro Social (IMSS). Se realiza esta propuesta de actuación ante casos sospechosos y confirmados de COVID‑19 en unidades de hemodiálisis intrahospitalaria.
Abstract
On January 30 2020, the World Health Organization (WHO) declared the COVID-19 outbreak as epidemiological emergency. Globally, various guidelines have been published for the safety of patients with chronic kidney disease (CKD) and health personnel working in hemodialysis centers. In Mexico, the prevalence of CKD is 12.2% and 60,000 patients receive some modality of renal replacement therapy at the Instituto Mexicano del Seguro Social (IMSS, Mexican Institute for Social Security). This proposal for action is made in the face of suspected and confirmed cases of COVID-19 in intrahospital hemodialysis units.
Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579(7798):265‑9. doi: 10.1038/s41586-020-2008-3
Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420‑2. doi: 10.1016/S2213-2600(20)30076-X
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507‑13. doi:10.1016/S0140-6736(20)30211-7
Wu Z, McGoogan JM. Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):7‑10. doi:10.1001/jama.2020.2648
Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, et al. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Ann Intern Med. 2020;172(9):577-582.. doi: 10.7326/M20-0504
Eckardt KU, Coresh J, Devuyst O, Johnson RJ, Köttgen A, Levey AS, et al. Evolving importance of kidney disease: From subspecialty to global health burden. Lancet. 2013;382(9887):158‑69. doi: 10.1016/S0140-6736(13)60439-0
Institute for Health Metrics and Evaluation. Global Burden of Disease Study 2017 (GBD 2017) Data Resources. Global Health Data Exchange. Seattle, Washington: University of Washington, GHDx. Disponible en http://ghdx.healthdata.org/gbd-2017
Institute for Health Metrics and Evaluation. GBD Compare. IHME Viz Hub. Global Health Data Exchange. Seattle, Washington: University of Washington, GHDx; 2013.
Agudelo-Botero M, Valdez-Ortiz R, Giraldo-Rodríguez L, González-Robledo MC, Mino-León D, Rosales-Herrera MF, et al. Overview of the burden of chronic kidney disease in Mexico: secondary data analysis based on the Global Burden of Disease Study 2017. BMJ Open. 2020;10(3):e035285. doi: 10.1136/bmjopen-2019-035285.
Tamayo-y Orozco JA, Lastiri‑Quirós HS. La enfermedad renal crónica en México. Hacia una política nacional para enfrentarla. México: Academia Nacional de Medicina de México; 2016. Disponible en https://www.anmm.org.mx/publicaciones/ultimas_publicaciones/ENF-RENAL.pdf
Sociedad Española de Nefrología. Comunicado [de la] Sociedad Española de Nefrología sobre la enfermedad COVID‑19. España: SEN; [sin fecha de publicación]. Disponible en https://www.senefro.org/modules.php?name=noticias&d_op=view&idnew=1172
Ma Y, Diao B, Lv X, Zhu J, Liang W, Liu L, et al. 2019 novel coronavirus disease in hemodialysis (HD) patients: Report from one HD center in Wuhan, China. MedRxiv. Disponible en https://www.medrxiv.org/content/10.1101/2020.02.24.20027201v3.full.pdf+html
De Francisco ALM, Pérez‑Canga JL. Coronavirus y Riñón. Nefrología al Día. Últimas novedades 1 de Abril de 2020. Madrid, España: Sociedad Española de Nefrología; Actualización completa 9 de junio de 2020. Disponible en: https://www.nefrologiaaldia.org/es-articulo-coronavirus-rinon-actualizacion-completa-09-305
Rombolà G, Heidempergher M, Pedrini L, Farina M, Aucella F, Messa P, et al. Practical indications for the prevention and management of SARS-CoV-2 in ambulatory dialysis patients: lessons from the first phase of the epidemics in Lombardy. J Nephrol. 2020;(0123456789):1‑4. doi: 10.1007/s40620-020-00727-y
Sociedad Latinoamericana de Nefrología e Hipeertensión (SLANH), Sociedad de Trasplantes de América Latina y el Caribe (STALYC), Asociación Panamericana de Infectología (API). Recomendaciones para el manejo de pacientes portadores de enfermedad renal frente a la epidemia de coronavirus (COVID‑19). [Sin lugar de publicación]: SLANH, STALYC, API; 13 de marzo de 2020. pp. 1‑10. Disponible en https://slanh.net/recomendaciones-para-el-manejo-de-pacientes-portadores-de-enfermedad-renal-frente-a-la-epidemia-de-coronavirus-covid-19/
Meijers B, Messa P, Ronco C. Safeguarding the Maintenance Hemodialysis Patient Population during the Coronavirus Disease 19 Pandemic. Blood Purif. 2020;49:259- 264. doi: 10.1159/000507537.
Basile C, Combe C, Pizzarelli F, Covic A, Davenport A, Kanbay M, et al. Recommendations for the prevention, mitigation and containment of the emerging SARS-CoV-2 (COVID-19) pandemic in haemodialysis centres. Nephrol Dial Transplant. 2020;2:1‑4. doi: 10.1093/ndt/gfaa069
Naicker S, Yang CW, Hwang SJ, Liu BC, Chen JH, Jha V. The Novel Coronavirus 2019 epidemic and kidneys. Kidney Int. 2020;1‑5. doi: 10.1016/j.kint.2020.03.001
Centers for Disease Control and Prevention. Interim Additional Guidance for Infection Prevention and Control Recommendations for Patients with Suspected or Confirmed COVID-19 in Outpatient Hemodialysis Facilities [Internet]. USA: Centers for Disease Control and Prevention; actualizado 23 de mayo de 2020. Disponible en https://www.cdc.gov/coronavirus/2019-ncov/hcp/dialysis.html
International Society of Nephrology. Recommendations for the Novel Coronavirus 2019 Epidemic. Brussels, Belgium: ISN; [sin fecha de publicación]. Disponible en https://www.theisn.org/covid19/recommendations
Nucamendi-Cervantes GC. Oficio No. DGE-DG-DVEENT 02595 2020. México: Secretaría de Salud, Dirección de Vigilancia Epidemiológica de Enfermedades No Transmisibles. Disponible en http://cuajimalpa.cdmx.gob.mx/wp-content/uploads/2020/03/OFICIO-CONAVE-23-03-20.pdf.pdf.pdf.pdf.pdf.pdf
Kliger AS, Cozzolino M, Jha V, Harbert G, Ikizler TA. Managing the COVID-19 pandemic: international comparisons in dialysis patients. Kidney Int. 2020;98(1):12‑16. doi: 10.1016/j.kint.2020.04.007
Kliger AS, Silberzweig J. Mitigating Risk of COVID-19 in Dialysis Facilities. Clin J Am Soc Nephrol. 2020;15(5):707‑9. doi: 10.2215/CJN.03340320
Centers for Disease Control and Prevention. Strategies to Optimize the Supply of PPE and Equipment. USA: CDC; actualizado el 16 de julio de 2020. Disponible en: https://www.cdc.gov/coronavirus/2019-ncov/hcp/ppe-strategy/index.html